Chemoinformaics analysis of Bicyclo[3.1.1]hept-2-ene, 4-ethoxy-2,6,6-trimethyl-
| Molecular Weight | 180.291 | nRot | 2 |
| Heavy Atom Molecular Weight | 160.131 | nRig | 8 |
| Exact Molecular Weight | 180.151 | nRing | 3 |
| Solubility: LogS | -3.939 | nHRing | 0 |
| Solubility: LogP | 3.585 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 34.1779 |
| nHD | 0 | BPOL | 21.8001 |
| QED | 0.593 |
| Synth | 4.794 |
| Natural Product Likeliness | 2.307 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.066 |
| Pgp-sub | 0.002 |
| HIA | 0.004 |
| CACO-2 | -4.399 |
| MDCK | 0.0000184 |
| BBB | 0.734 |
| PPB | 0.83892 |
| VDSS | 1.342 |
| FU | 0.120953 |
| CYP1A2-inh | 0.132 |
| CYP1A2-sub | 0.566 |
| CYP2c19-inh | 0.199 |
| CYP2c19-sub | 0.891 |
| CYP2c9-inh | 0.258 |
| CYP2c9-sub | 0.225 |
| CYP2d6-inh | 0.008 |
| CYP2d6-sub | 0.621 |
| CYP3a4-inh | 0.031 |
| CYP3a4-sub | 0.358 |
| CL | 10.04 |
| T12 | 0.084 |
| hERG | 0.006 |
| Ames | 0.007 |
| ROA | 0.058 |
| SkinSen | 0.046 |
| Carcinogencity | 0.038 |
| EI | 0.618 |
| Respiratory | 0.833 |
| NR-Aromatase | 0.006 |
| Antiviral | No |
| Prediction | 0.603434 |